Clinical Trial Update: A Pharmacodynamic Study of the Apheresis Product of Multiple Myeloma Patients Undergoing Quad-induction Followed by Motixafortide + G-CSF Mobilization [Phase 1]

View source ↗

Summary

Completed Phase 1 pharmacodynamic study evaluating the apheresis product from multiple myeloma patients undergoing quad-induction followed by Motixafortide plus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Filgrastim (filgrastim)
• Motixafortide (motixafortide)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED